Chancity

Annual Targeted Protein Degradation Summit 2026

A TPD and induced proximity summit focused on research from discovery through clinical development.

The Omni Boston Hotel at the Seaport, Boston, MA

Date
October 26, 2026
Venue
The Omni Boston Hotel at the Seaport, Boston, MA

TL;DR

  • The 2026 summit starts October 26 in Boston, Massachusetts.
  • The venue is The Omni Boston Hotel at the Seaport.
  • Its stated scope spans targeted protein degradation research from early discovery to clinical development.

About

The summit returns as a forum for targeted protein degradation and induced proximity, with clinical validation among its stated themes. Its program is described as covering work from early discovery through clinical development, including target selection, degrader design, funding and partnerships.

Who you'll find in the room

Biotechs

Biotech organizations are listed among the attendee groups.

Pharma

Pharmaceutical companies are listed among the attendee groups.

Solution providers

Solution providers are listed among the attendee groups.

Academia

Academic participants are listed among the attendee groups.

Start-ups

Start-ups are listed among the attendee groups.

Featured speakers

23 listed

Randy Teel

Katherine Yen

Stacy Blain

Yaron Sfadyah

Adrian Gottschalk

Anita Bellail

Catherine Sabatos-Peyton

Brian Safina

Phil Chamberlain

Arthur Sands

Beth Hoffman

Benedict Cross

Ray Deshaies

Nicki Thompson

Wolf Ruprecht Wiedemeyer

Ryan Potts

Debora Bonenfant

Stuart Schreiber

Nan Ji

Hyunsun Jo

Lan Huang

Adam Yaari

Kara Carter

Venue & travel

Venue

The Omni Boston Hotel at the Seaport

Questions people ask

5 answered

The summit starts on October 26, 2026.

The 2026 summit is at The Omni Boston Hotel at the Seaport in Boston, Massachusetts.

Listed attendee groups include biotech and pharmaceutical companies, solution providers, academia and start-ups.

It is most useful for drug discovery and development scientists and business development staff at biotechs and pharma working on degraders or induced proximity, since the program spans early discovery to clinical data and includes speakers linked to companies such as Arvinas, Amgen and C4 Therapeutics. Those outside this modality, or seeking a broad drug discovery overview, would get less from it, and the focus on funding and partnering suits dealmakers more than bench generalists.

Attendees at Boston biotech conferences usually wear business casual, such as chinos or slacks with a button-down or sweater, and dressier for investor-facing roles. Late October in Boston is cool, so a light jacket is sensible.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.

Also listed in